Ajit G. Thomas

6.8k citations

84 papers · 5.0k indexed · 1 hit paper · h-index 34

Molecular Biology top 2%
Cancer Research top 1%
Pulmonary and Respiratory Medicine top 1%
Cellular and Molecular Neuroscience top 2%
Oncology top 5%

Co-authors: Barbara S. Slusher Camilo Rojas Brent R. Stockwell Miki Hayano Eric D. Lee Caroline E. Gleason Matthew Welsch Nicholas P. Tatonetti
Topics: Neuroscience and Neuropharmacology Research (17 papers)Neuroinflammation and Neurodegeneration Mechanisms (14 papers)Neuropeptides and Animal Physiology (14 papers)
Cited by: Cancer Research Biological Psychiatry Biochemistry
Journals: Proceedings of the National Academy of Sciences Nature Medicine PLoS ONE
Partner nations: United States Czechia Japan

In The Last Decade

Ajit G. Thomas

82 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

2014 1.6k citations Ajit G. Thomas, Barbara S. Slusher et al. profile →

Peers

Countries citing papers authored by Ajit G. Thomas

Since Specialization

Citations

This map shows the geographic impact of Ajit G. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajit G. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajit G. Thomas more than expected).

Fields of papers citing papers by Ajit G. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajit G. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajit G. Thomas. The network helps show where Ajit G. Thomas may publish in the future.

Co-authorship network of co-authors of Ajit G. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Ajit G. Thomas. A scholar is included among the top collaborators of Ajit G. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajit G. Thomas. Ajit G. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits 2025 ·Neurotherapeutics ·(unknown),Yannan Li,Ajit G. Thomas,A. Sharma,Wathsala Liyanage,(unknown),Lukáš Tenora,(unknown),(unknown),Niyada Hin,(unknown),Pavel Majer,Rangaramanujam M. Kannan,Takashi Tsukamoto,Gianluca Ursini,Rana Rais,Barbara S. Slusher,Xiaolei Zhu	0
2	An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice 2025 ·Science Translational Medicine ·Ankit Uniyal,Niyada Hin,(unknown),Qian Xu,Qian Huang,(unknown),Ajit G. Thomas,(unknown),(unknown),Jing Liu,(unknown),Xiang Cui,Peng Qi,(unknown),Rana Rais,Barbara S. Slusher,Srinivasa N. Raja,Xinzhong Dong,Takashi Tsukamoto,Yun Guan	0
3	Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a]pyrimidin-3-amine scaffold 2023 ·European Journal of Medicinal Chemistry ·(unknown),Ajit G. Thomas,(unknown),(unknown),Niyada Hin,(unknown),(unknown),Lukáš Tenora,Arindom Pal,Jesse Alt,Ying Wu,(unknown),Rana Rais,Barbara S. Slusher,Takashi Tsukamoto	2
4	T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade 2023 ·JCI Insight ·Kyungho Lee,Elizabeth A. Thompson,(unknown),Chirag H. Patel,Johanna T. Kurzhagen,Phillip M. Pierorazio,Lois J. Arend,Ajit G. Thomas,Sanjeev Noel,Barbara S. Slusher,Hamid Rabb	14
5	Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice 2023 ·Pharmaceutics ·(unknown),Carolyn Tallon,Xiaolei Zhu,(unknown),Silvia Picciolini,Ajit G. Thomas,Lukáš Tenora,Wathsala Liyanage,(unknown),Alice Gualerzi,Rangaramanujam M. Kannan,Marzia Bedoni,Rana Rais,Barbara S. Slusher	5
6	A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis 2023 ·Science Translational Medicine ·Diane E. Peters,(unknown),Lukáš Tenora,(unknown),(unknown),Xiaolei Zhu,Shinji Sakamoto,(unknown),Manisha Pradhan,Jesse Alt,Ajit G. Thomas,Pavel Majer,Rana Rais,Christine McDonald,Barbara S. Slusher	9
7	Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy 2023 ·Journal of Controlled Release ·Fan Zhang,Zhi Zhang,Jesse Alt,Siva P. Kambhampati,Anjali Sharma,Sarabdeep Singh,Elizabeth Nance,Ajit G. Thomas,Camilo Rojas,Rana Rais,Barbara S. Slusher,Rangaramanujam M. Kannan,Sujatha Kannan	6
8	Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug 2022 ·Science Advances ·Rana Rais,Kathryn M. Lemberg,Lukáš Tenora,Matthew L. Arwood,Arindom Pal,Jesse Alt,Ying Wu,Jenny Lam,(unknown),Liang Zhao,Diane E. Peters,Carolyn Tallon,Rajeev Pandey,Ajit G. Thomas,Ranjeet Prasad Dash,Tanguy Y. Seiwert,Pavel Majer,Robert D. Leone,Jonathan D. Powell,Barbara S. Slusher	77
9	Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice 2022 ·Pharmaceutics ·Carolyn Tallon,(unknown),Anjali Sharma,Arindom Pal,(unknown),Ajit G. Thomas,Seung‐Wan Yoo,Kristen R. Hollinger,(unknown),(unknown),Sujatha Kannan,Norman J. Haughey,Rangaramanujam M. Kannan,Rana Rais,Barbara S. Slusher	15
10	Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV 2022 ·Neurobiology of Disease ·Xiaolei Zhu,Kristen R. Hollinger,Yiyao Huang,Alejandra Borjabad,(unknown),Tanina Arab,Ajit G. Thomas,(unknown),(unknown),Andrey Turchinovich,Kenneth W. Witwer,David J. Volsky,Norman J. Haughey,Barbara S. Slusher	16
11	High Throughput Screening Cascade To Identify Human Aspartate N-Acetyltransferase (ANAT) Inhibitors for Canavan Disease 2021 ·ACS Chemical Neuroscience ·(unknown),Ajit G. Thomas,Jesse Alt,Niyada Hin,(unknown),Shunyou Long,Takashi Tsukamoto,Camilo Rojas,Huijun Wei,Barbara S. Slusher	6
12	Inhibition of neutral sphingomyelinase 2 promotes remyelination 2020 ·Science Advances ·Seung-Wan Yoo,Amit Agarwal,Matthew D. Smith,Saja S. Khuder,Emily G. Baxi,Ajit G. Thomas,Camilo Rojas,Mohammed Moniruzzaman,Barbara S. Slusher,Dwight E. Bergles,Peter A. Calabresi,Norman J. Haughey	30
13	Preventing Allograft Rejection by Targeting Immune Metabolism 2015 ·Cell Reports ·(unknown),Ying-Chun Lo,Chih‐Hsien Cheng,Georg J. Furtmüller,(unknown),Vinícius Andrade‐Oliveira,Ajit G. Thomas,Caitlyn E. Bowman,Barbara S. Slusher,Michael J. Wolfgang,Gerald Brandacher,Jonathan D. Powell	144
14	Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Wan Seok Yang,(unknown),Ajit G. Thomas,Barbara S. Slusher,Brent R. Stockwell	105
15	Synthesis of kojic acid derivatives as secondary binding site probes of d-amino acid oxidase 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mithun Raje,Niyada Hin,Bridget Duvall,Dana Ferraris,James F. Berry,Ajit G. Thomas,Jesse Alt,Camilo Rojas,Barbara S. Slusher,Takashi Tsukamoto	20
16	Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1 2010 ·Cancer Research ·Meghan J. Seltzer,Bryson D. Bennett,Avadhut D. Joshi,Ping Gao,Ajit G. Thomas,Dana Ferraris,Takashi Tsukamoto,Camilo Rojas,Barbara S. Slusher,Joshua D. Rabinowitz,Chi V. Dang,Gregory J. Riggins	410
17	Bioanalysis of N-acetyl-aspartyl-glutamate as a marker of glutamate carboxypeptidase II inhibition 2010 ·Analytical Biochemistry ·Ajit G. Thomas,Camilo Rojas,Jeanette R. Hill,M.C. Shaw,Barbara S. Slusher	7
18	Glutamate Carboxypeptidase II (NAALADase) Inhibition as a Novel Therapeutic Strategy 2006 ·Advances in experimental medicine and biology ·Ajit G. Thomas,Krystyna M. Wozniak,Takashi Tsukamoto,David C. Calvin,Ying Wu,Camilo Rojas,James J. Vornov,Barbara S. Slusher	23
19	Glutamate Carboxypeptidase II Inhibition as a Novel Therapeutic Target 2005 ·Kluwer Academic Publishers eBooks ·Camilo Rojas,Ajit G. Thomas,Pavel Majer,Takashi Tsukamoto,(unknown),James J. Vornov,Kinga Woźniak,Barbara S. Slusher	4
20	Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II 2003 ·Bioorganic & Medicinal Chemistry Letters ·Doris Stoermer,Qun Liu,(unknown),(unknown),Ajit G. Thomas,Camilo Rojas,Barbara S. Slusher,Takashi Tsukamoto	40

About Ajit G. Thomas

Ajit G. Thomas is a scholar working on Biological Psychiatry, Neurology and Biochemistry, having authored 84 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Neuropeptides and Animal Physiology (14 papers). The work is most often cited by research in Cancer Research (1.7k citations), Biological Psychiatry (159 citations) and Biochemistry (434 citations). Ajit G. Thomas has collaborated with scholars based in United States, Czechia and Japan. Frequent co-authors include Barbara S. Slusher, Camilo Rojas, Brent R. Stockwell, Miki Hayano, Eric D. Lee, Caroline E. Gleason, Matthew Welsch, Nicholas P. Tatonetti, Rachid Skouta and Scott J. Dixon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact